Russian Energy Utility Mosenergo (AO) Upgraded To 'BB/ruAA' On Improved Performance; Outlook Stable May 11

  • ID: 1807787
  • May 2011
  • Region: Russia
  • Standard & Poors
1 of 3

Russia-based energy utility Mosenergo reported a strong financial performance and cash flow generation in 2010. Our view of an improved financial risk profile supports a higher stand-alone credit profile assessment. We are raising our ratings on Mosenergo to 'BB/ruAA' from 'BB-/ruAA-'. The stable outlook reflects our view that Mosenergo's key credit metrics and liquidity will likely remain commensurate for the ratings. MOSCOW (Standard & Poor's) May 27, 2011--Standard & Poor's Ratings Services said that it had raised its long-term corporate credit and Russia national scale ratings on Russia-based electricity and heat generator Mosenergo (AO) to 'BB/ruAA' from 'BB-/ruAA-'. The outlook is stable. The upgrade reflects a combination of strong operating cash-flow generation at Mosenergo, which we expect to be sustainable,...

Companies mentioned in this report are:
- Mosenergo (AO)

Action: Outlook: Stable
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Mosenergo (AO)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.